CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,770,312 | -7.2% | 921,327 | +6.7% | 0.00% | 0.0% |
| Q2 2023 | $11,602,873 | -42.6% | 863,309 | -29.2% | 0.00% | -50.0% |
| Q1 2023 | $20,213,921 | -12.9% | 1,219,175 | -2.3% | 0.01% | -14.3% |
| Q4 2022 | $23,201,901 | +48.7% | 1,247,414 | +2.6% | 0.01% | +16.7% |
| Q3 2022 | $15,600,000 | +88.4% | 1,215,911 | +2.9% | 0.01% | +100.0% |
| Q2 2022 | $8,282,000 | +20.2% | 1,181,407 | +42.1% | 0.00% | +50.0% |
| Q1 2022 | $6,893,000 | +24.2% | 831,365 | +1.4% | 0.00% | 0.0% |
| Q4 2021 | $5,551,000 | +30.7% | 819,796 | +2.3% | 0.00% | +100.0% |
| Q3 2021 | $4,247,000 | -7.6% | 801,244 | +0.3% | 0.00% | -50.0% |
| Q2 2021 | $4,596,000 | +2.8% | 799,239 | -17.6% | 0.00% | 0.0% |
| Q1 2021 | $4,471,000 | +34.5% | 969,707 | -2.5% | 0.00% | +100.0% |
| Q4 2020 | $3,323,000 | +24.3% | 994,740 | +10.5% | 0.00% | 0.0% |
| Q3 2020 | $2,674,000 | -36.1% | 900,298 | -0.6% | 0.00% | -50.0% |
| Q2 2020 | $4,184,000 | +25.6% | 905,593 | +4.7% | 0.00% | 0.0% |
| Q1 2020 | $3,330,000 | +9.6% | 864,859 | +6.8% | 0.00% | 0.0% |
| Q4 2019 | $3,037,000 | +0.2% | 809,820 | +41.8% | 0.00% | 0.0% |
| Q3 2019 | $3,032,000 | +248.9% | 570,978 | +152.4% | 0.00% | +100.0% |
| Q2 2019 | $869,000 | -24.7% | 226,188 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $1,154,000 | +187.8% | 226,188 | +8.5% | 0.00% | – |
| Q4 2018 | $401,000 | -49.1% | 208,404 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $788,000 | +21.0% | 208,404 | 0.0% | 0.00% | – |
| Q2 2018 | $651,000 | +47.3% | 208,404 | +12.7% | 0.00% | – |
| Q1 2018 | $442,000 | -24.1% | 184,904 | +24.3% | 0.00% | – |
| Q4 2017 | $582,000 | +91.4% | 148,704 | +23.4% | 0.00% | – |
| Q3 2017 | $304,000 | -8.7% | 120,500 | 0.0% | 0.00% | – |
| Q2 2017 | $333,000 | +164.3% | 120,500 | +12.3% | 0.00% | – |
| Q1 2016 | $126,000 | -52.1% | 107,345 | 0.0% | 0.00% | – |
| Q4 2015 | $263,000 | -18.6% | 107,345 | 0.0% | 0.00% | – |
| Q3 2015 | $323,000 | -27.3% | 107,345 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $444,000 | – | 107,345 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |